Resources

Type of publications
Regions
Diseases

5192 results found

2022 ∙ Nweze, K. Hart-Pinto, A. Philip, L. Mortimer, K. Whitehead, K. A. Shokrollahi, K.

Recommendations for Influenza Vaccination in Burns Patients Based on a Systematic Review of the Evidence

  • All age groups
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Mardiyan Kurniawati, E. Rahmawati, N. A.

Records of antibodies in breast milk in postpartum women who have been vaccinated or exposed to COVID-19: A systematic review

  • Parents/caregivers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Puig-Barbera, J. Tamames-Gomez, S. Plans-Rubio, P. Eiros-Bouza, J. M.

Relative Effectiveness of Cell-Cultured versus Egg-Based Seasonal Influenza Vaccines in Preventing Influenza-Related Outcomes in Subjects 18 Years Old or Older: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
High
2022 ∙ Zhang, J. Cao, J. Ye, Q.

Renal Side Effects of COVID-19 Vaccination

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Lane, S. Yeomans, A. Shakir, S.

Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature

  • Adolescents
  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Parker, E. P. K. Desai, S. Marti, M. Nohynek, H. Kaslow, D. C. Kochhar, S. O'Brien, K. L. Hombach, J. Wilder-Smith, A.

Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review

  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Kroon, F. P. B. Najm, A. Alunno, A. Schoones, J. W. Landewe, R. B. M. Machado, P. M. Navarro-Compan, V.

Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations

  • All age groups
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Tsiorou, K. Sarantaki, A.

Risk Assessment of COVID-19 Vaccination Among Childbearing Women

  • Adults
  • Adolescents
  • Pregnant women
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Petrá M Janovská, D. Čelko, A. M. D Selinger, E. Dole Neradov Franklová, M. Dlouhý, P. Rosina, J. Lesná, I. K.

Risk factors affecting COVID-19 vaccine effectiveness identified from 290 cross-country observational studies until February 2022: a meta-analysis and meta-regression

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Boender, T. S. Bartmeyer, B. Coole, L. Wichmann, O. Harder, T.

Risk of Guillain-Barré syndrome after vaccination against human papillomavirus: A systematic review and meta-analysis, 1 January 2000 to 4 April 2020

  • Adolescents
  • Adults
  • Older adults
  • Human papillomavirus (HPV)
  • Safety
Methodological quality (AMSTAR 2):
High
Loading...